Tyra Biosciences, Inc. (TYRA) Tops Q2 EPS by 6c

Tyra Biosciences, Inc. (NASDAQ: TYRA) reported Q2 EPS of ($0.47), $0.06 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tyra Biosciences, Inc. (TYRA) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Gamma Resources raises private placement ceiling to $1.75M
• FDA approves Takeda's rusfertide for polycythemia vera treatment